Enlivex Ltd. (NASDAQ: ENLV) announced it has dosed the first patient at a United States clinical site in its Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE